Suppr超能文献

少突胶质细胞再生:其在多发性硬化症髓鞘替代和神经保护中的意义。

Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

作者信息

Chamberlain Kelly A, Nanescu Sonia E, Psachoulia Konstantina, Huang Jeffrey K

机构信息

Department of Biology, Georgetown University, Washington, D.C., USA; Interdisciplinary Program in Neuroscience, Georgetown University, Washington, D.C., USA.

Department of Biology, Georgetown University, Washington, D.C., USA.

出版信息

Neuropharmacology. 2016 Nov;110(Pt B):633-643. doi: 10.1016/j.neuropharm.2015.10.010. Epub 2015 Oct 22.

Abstract

Oligodendrocytes readily regenerate and replace myelin membranes around axons in the adult mammalian central nervous system (CNS) following injury. The ability to regenerate oligodendrocytes depends on the availability of neural progenitors called oligodendrocyte precursor cells (OPCs) in the adult CNS that respond to injury-associated signals to induce OPC expansion followed by oligodendrocyte differentiation, axonal contact and myelin regeneration (remyelination). Remyelination ensures the maintenance of axonal conduction, and the oligodendrocytes themselves provide metabolic factors that are necessary to maintain neuronal integrity. Recent advances in oligodendrocyte regeneration research are beginning to shed light on critical intrinsic signals, as well as extrinsic, environmental factors that regulate the distinct steps of oligodendrocyte lineage progression and myelin replacement under CNS injury. These studies may offer novel pharmacological targets for regenerative medicine in inflammatory demyelinating disorders in the CNS such as multiple sclerosis. This article is part of the Special Issue entitled 'Oligodendrocytes in Health and Disease'.

摘要

在成年哺乳动物中枢神经系统(CNS)受伤后,少突胶质细胞能够迅速再生并替换轴突周围的髓鞘膜。少突胶质细胞的再生能力取决于成年中枢神经系统中称为少突胶质前体细胞(OPC)的神经祖细胞的可用性,这些细胞对损伤相关信号作出反应,诱导OPC扩增,随后少突胶质细胞分化、轴突接触和髓鞘再生(髓鞘重塑)。髓鞘重塑确保轴突传导的维持,少突胶质细胞本身提供维持神经元完整性所需的代谢因子。少突胶质细胞再生研究的最新进展开始揭示关键的内在信号以及外在环境因素,这些因素在中枢神经系统损伤时调节少突胶质细胞谱系进展和髓鞘替换的不同步骤。这些研究可能为中枢神经系统炎性脱髓鞘疾病(如多发性硬化症)的再生医学提供新的药理学靶点。本文是名为“健康与疾病中的少突胶质细胞”特刊的一部分。

相似文献

3
Remyelination: the true regeneration of the central nervous system.髓鞘再生:中枢神经系统的真正再生。
J Comp Pathol. 2013 Aug-Oct;149(2-3):242-54. doi: 10.1016/j.jcpa.2013.05.004. Epub 2013 Jul 5.
5
Cells of the oligodendroglial lineage, myelination, and remyelination.少突胶质细胞谱系的细胞、髓鞘形成和髓鞘再生。
Biochim Biophys Acta. 2011 Feb;1812(2):184-93. doi: 10.1016/j.bbadis.2010.09.010. Epub 2010 Sep 29.
8
Remyelination in multiple sclerosis.多发性硬化症中的髓鞘再生
Int Rev Neurobiol. 2007;79:589-620. doi: 10.1016/S0074-7742(07)79026-8.

引用本文的文献

8
Development of Brain-Derived Bioscaffolds for Neural Progenitor Cell Culture.用于神经祖细胞培养的脑源性生物支架的开发。
ACS Pharmacol Transl Sci. 2023 Jan 17;6(2):320-333. doi: 10.1021/acsptsci.2c00232. eCollection 2023 Feb 10.
10
Effect of Anesthesia on Oligodendrocyte Development in the Brain.麻醉对脑内少突胶质细胞发育的影响。
Front Syst Neurosci. 2022 May 18;16:848362. doi: 10.3389/fnsys.2022.848362. eCollection 2022.

本文引用的文献

6
Pathological mechanisms in progressive multiple sclerosis.进行性多发性硬化症的病理机制。
Lancet Neurol. 2015 Feb;14(2):183-93. doi: 10.1016/S1474-4422(14)70256-X.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验